aTyr Pharma Inc. (LIFE): Share Price, Stock Analysis, Annual Report | Value Research Get aTyr Pharma Inc. (LIFE)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

aTyr Pharma Inc. (LIFE)

NASDAQ: LIFE

  • Market Capitalisation info

    $113 Mln


  • 12 Month Earnings info

    $-39 Mln

  • Price to Earnings info

    --

$3.97

As on 17-Aug-2022 16:00 EDT

up-down-arrow $-0.18-4.34%

  • Prev Close info

    $4.15

  • Day's Openinfo

    $4.16

  • Today's Highinfo

    $4.18

  • Today's Lowinfo

    $3.86

  • Today's Volumeinfo

    262,153

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
aTyr Pharma (LIFE)
-46.85 34.58 28.90 -15.35 10.79 -36.52 --
S&P BSE Sensex*
3.13 11.75 10.61 7.68 17.17 13.57 13.00
S&P Small-Cap 600
-8.64 12.61 8.05 -4.66 11.67 8.92 10.84
As on 17-Aug-2022  |  *As on 18-Aug-2022
2021
2020
2019
2018
2017
2016
aTyr Pharma (LIFE)
92.53 -6.95 -39.91 -85.69 62.79 -78.13
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Pres, CEO & Director

        Dr. Sanjay S. Shukla M.D., M.S.

        Chief Financial Officer

        Ms. Jill M. Broadfoot

        Headquarters

        San Diego, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $112.51 Mln

        • Revenue (TTM) info

          $0.00 Mln

        • Earnings (TTM) info

          $-38.77 Mln

        • Cash info

          $98.67 Mln

        • Total Debt info

          $1.15 Mln

        • Insider's Holding

          3.08%

        • Liquidity info

          Low

        • 52 Week range info

          $2.60 - 13.10

        • Shares outstanding info

          28,056,200

        • 10 Years Aggregate:

          CFO: $506.38 Mln

          EBITDA: $-246.14 Mln

          Net Profit: $124.35 Mln

        About The Company

        • Business

          aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States.

        • IPO Date

          07-May-2015

        • Pres, CEO & Director

          Dr. Sanjay S. Shukla M.D., M.S.

        • Chief Financial Officer

          Ms. Jill M. Broadfoot

        • Listing info

          NASDAQ: LIFE

        • Country

          United States

        • Headquarters info

          San Diego, CA

        • Website info

          https://www.atyrpharma.com